FDA Proposes Consolidation of Drug Regulations in Response to REGO Initiative

Summary

The Food and Drug Administration (FDA) is proposing to combine a list of drugs previously designated as new drugs into one section, aiming to make the regulations more concise and efficient, in response to the President's regulatory reinvention initiative (REGO).